OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nootropics as Cognitive Enhancers: Types, Dosage and Side Effects of Smart Drugs
Matěj Malík, Pavel Tlustoš
Nutrients (2022) Vol. 14, Iss. 16, pp. 3367-3367
Open Access | Times Cited: 61

Showing 26-50 of 61 citing articles:

Clinical Pharmacology of Vinpocetine: Properties Revisited and Introduction of a Population Pharmacokinetic Model for Its Metabolite, Apovincaminic Acid (AVA)
Zvonimir Petrić, Paulo Paixão, Augusto Filipe, et al.
Pharmaceutics (2023) Vol. 15, Iss. 10, pp. 2502-2502
Open Access | Times Cited: 5

Selenium alleviates modafinil-induced neurobehavioral toxicity in rat via PI3K/Akt/mTOR/GSK3B signaling pathway and suppression of oxidative stress and apoptosis: in vivo and in silico study
Shaimaa A. Shehata, Eman Kolieb, Dina A. Ali, et al.
Environmental Science and Pollution Research (2023) Vol. 31, Iss. 1, pp. 458-480
Closed Access | Times Cited: 4

Targeting epigenetic mechanisms in amyloid-β–mediated Alzheimer’s pathophysiology: unveiling therapeutic potential
Jennie Z. Li, Nagendran Ramalingam, Shaomin Li
Neural Regeneration Research (2024) Vol. 20, Iss. 1, pp. 54-66
Open Access | Times Cited: 1

Enhancing Therapeutic Efficacy of Donepezil, an Alzheimer’s Disease Drug, by Diplazium esculentum (Retz.) Sw. and Its Phytochemicals
Woorawee Inthachat, Boonrat Chantong, Pornsiri Pitchakarn, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 3, pp. 341-341
Open Access | Times Cited: 1

Evaluation of nootropic and neuroprotective properties of Siddha drug Poorana Chandrothaya Chenthuram (PCC) in scopolamine-induced amnesia in mice
Chitra Balasubramanian, Ramakrishna Ramaswamy
Phytomedicine Plus (2024) Vol. 4, Iss. 3, pp. 100585-100585
Open Access | Times Cited: 1

Influencers and ‘brain building’ smart drugs: A content analysis of services and market activities of nootropic influencers over social media
Luke Cox, Timothy Piatkowski
Performance Enhancement & Health (2024), pp. 100289-100289
Closed Access | Times Cited: 1

Hacking the Cycle: Femtech, Internalized Surveillance, and Productivity
Alzbeta Hajkova, Tom A. Doyle
Philosophy & Technology (2024) Vol. 37, Iss. 4
Closed Access | Times Cited: 1

Docosahexaenoic Acid Plus Piracetam Versus Piracetam Alone for Treatment of Breath-Holding Spells in Children: A Randomized Clinical Trial
Abeer Ramadan, Amira Hamed Darwish
Pediatric Neurology (2023) Vol. 148, pp. 32-36
Closed Access | Times Cited: 3

The neuroprotective effects of Piracetam on cisplatin-induced cognitive decline
Maha ELBeltagy, Bann Khraisat, Lujain AlZoubi, et al.
International Journal of Neuroscience (2023), pp. 1-8
Open Access | Times Cited: 3

Pharmacotherapy for post-stroke aphasia: what are the options?
Marcelo L. Berthier, Guadalupe Dávila
Expert Opinion on Pharmacotherapy (2023) Vol. 24, Iss. 11, pp. 1221-1228
Closed Access | Times Cited: 2

Cognitive impairment in opioid use disorders: Is there a case for use of nootropics?
Gayatri Bhatia, Ragul Ganesh, Alok Kulkarni
Psychiatry Research (2023) Vol. 326, pp. 115335-115335
Closed Access | Times Cited: 2

A young patient at a neurologist’s appointment: features of diagnostics and therapy
M. V. Putilina
Meditsinskiy sovet = Medical Council (2023), Iss. 10, pp. 146-152
Open Access | Times Cited: 2

Exploring the Landscape of Alertness-Enhancing Drugs: A Contemporary Review
Triveni Turre, Ankita S. Raut, Apurva Deshmukh, et al.
International Journal of Advanced Research in Science Communication and Technology (2024), pp. 579-587
Open Access

Doğal Beyin Dopingleri: Bitkisel Nootropikler ve Bilişsel Etkileri
Kadriye Elif İmre, Funda Işık
İzmir Katip Çelebi Üniversitesi Sağlık Bilimleri Fakültesi Dergisi (2024) Vol. 9, Iss. 3, pp. 447-456
Open Access

Exploring Neuroprotective Botanical Remedies in Neurodegenerative Conditions: A Review
Ankit Sharma, Meenakshi Malhotra, Amar Pal Singh, et al.
Journal of Drug Delivery and Therapeutics (2024) Vol. 14, Iss. 5, pp. 137-140
Open Access

Ethnopharmacology: A Boon for Brain Aging
Mohamed Y. Zaky, Nahed S. Lamloum, Osama M. Ahmed
(2024), pp. 165-180
Closed Access

Exploring Cognitive Enhancement Technologies in the Workplace: A Systematic Literature Review
M. Pretorius, Agnis Stibe, Karel Stanz, et al.
Lecture notes in computer science (2024), pp. 303-317
Closed Access

Pharmacotherapy of older and senile patients. Review
Liana Kuprash, Tetyana Panteleymonova, Olena Kuprash
Ageing & Longevity (2024), Iss. 3 2024, pp. 139-147
Closed Access

A Standardized Single Dose of the Nootropic CILTEP® Has No Effect on Cognitive Performance in Healthy Elderly Participants
Nina Possemis, Stéphanie Caldenhove, Jos Prickaerts, et al.
Journal of Cognitive Enhancement (2024)
Open Access

POTENTIAL OF NATURAL SUBSTANCE USAGE IN SOUTH EAST ASIA FOR MEMORY ENHANCEMENT: A REVIEW
Xinyi Zhu, Shun Kuroki, Jessebel V. Gadot, et al.
ASEAN Journal of Psychiatry (2024) Vol. 25, Iss. 07
Closed Access

Cognitive Enhancers Consumption: Prevalence, Knowledge, and Determinants of Use Among Medical Students in Egypt, Sudan, and Jordan
Yousef Hawas, Motasem Ayoub, Esraa Esmail, et al.
Substance Use & Misuse (2024), pp. 1-6
Closed Access

Comparison of urinary excretion patterns among exposures to cosmetic preservative, herbicide, and nootropic stimulant in anti-doping analysis
I-Wen Lu, Mei‐Chich Hsu, Yu‐Tse Wu, et al.
Journal of Chromatography B (2024) Vol. 1251, pp. 124430-124430
Closed Access

Scroll to top